Clinical Trials Directory

Trials / Completed

CompletedNCT05671393

the Optimal Surveillance Frequency for Patients With Gastric Neuroendocrine Carcinoma

A Multi-institution Real-world Study of the Optimal Surveillance Frequency for Patients With Gastric Neuroendocrine Carcinoma

Status
Completed
Phase
Study type
Observational
Enrollment
801 (actual)
Sponsor
Fujian Medical University · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Due to lacking of evidence on surveillance for gastric neuroendocrine carcinoma (G-NEC), this study aimed to determine the optimal postsurgical surveillance strategy for G-NEC patients and compare its cost-effectiveness with traditional surveillance strategies.

Detailed description

The development of existing follow-up strategies is mainly based on experts' consensus and researches on recurrence patterns due to the lack of direct evidence and unified standards. On the one hand, it is unreasonable to carry out the same postoperative surveillance for all G-NEC patients. In addition to the early detection of recurrence, the optimal follow-up strategy should also balance cost and effectiveness. There were no criteria for the arrangement of follow-up in different guidelines, and the optimal postoperative follow-up strategy for patients with G-NEC remains unclear. Patients with G-NEC from 21 centers in China were included. Cost-effectiveness were assessed by Markov model.

Conditions

Timeline

Start date
2008-01-01
Primary completion
2016-12-01
Completion
2022-12-15
First posted
2023-01-04
Last updated
2023-01-04

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05671393. Inclusion in this directory is not an endorsement.

the Optimal Surveillance Frequency for Patients With Gastric Neuroendocrine Carcinoma (NCT05671393) · Clinical Trials Directory